Overview
Tatiana M. Prowell, MD is Associate Professor of Oncology in the Division of Women's Malignancies at the Johns Hopkins Kimmel Comprehensive Cancer Center and Breast Cancer Scientific Liaison to the U.S. Food and Drug Administration. She was the principal architect of FDA’s policy on accelerated approval using pathological complete response as a novel regulatory endpoint in the neoadjuvant high-risk breast cancer setting, and a member of the Biden Cancer Moonshot Blue Ribbon Panel Cancer Immunology Working Group. A frequent public speaker, she is a three-time recipient of FDA’s Excellence in Communication Award. She is a past Giants of Cancer Care Award finalist, the recipient of the 2019 John and Samuel Bard Medal in Science or Medicine, and the recipient of a 2020 Webby Special Achievement Award for her effective use of social media during the pandemic. A passionate medical educator and mentor, she was Chair of the 2020 ASCO Annual Meeting Education Committee and has served for many years on the faculty of the Vail ASCO/AACR Methods in Clinical Cancer Research Workshop, the Society for Translational Oncology Fellows’ Forum, the Dana Farber Clinical Investigator Seminar Series, and the FDA-ASCO Fellows’ Day Workshop, among several others. Dr. Prowell staffs the second opinion breast cancer clinic and teaches in the Johns Hopkins School of Medicine MD/PhD medical ethics course and the medical oncology fellowship training program. Her areas of particular clinical and research interest include development of novel agents for breast cancer, neoadjuvant therapy for breast cancer, brain metastases, decentralized clinical trials, and the unique challenges of breast cancer in younger women. Dr. Prowell received her BA degree from Bard College in literature and her MD degree from the Johns Hopkins School of Medicine with election to the Phi Beta Kappa and Alpha Omega Alpha honor societies. She completed her residency and fellowship training at Johns Hopkins Hospital. She tweets as @tmprowell about cancer, public health, COVID-19, medical education, health equity, and women in medicine.
Her clinical expertise encompasses Triple-Negative Breast Cancer.
Dr. Prowell is board certified in American Board Of Internal Medicine. Dr. Prowell is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Viragh BLDG 10th FL, Baltimore, MD 21287
Additional Areas of Focus
Dr. Prowell has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Stoler Outpatient Cancer Clinic
Maria Baer is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Baer is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Splenectomy. Dr. Baer is board certified in American Board Of Internal Medicine - Hematology, 1984 and American Board Of Internal Medicine - Internal Medicine, 1983. Dr. Baer is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Aaron Rapoport is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Rapoport is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Rapoport is board certified in American Board Of Internal Medicine - Internal Medicine, 1989 and American Board Of Internal Medicine - Hematology, 1992. Dr. Rapoport is currently accepting new patients.
Oto Head & Neck Multi-D Clinic
Ranee Mehra is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Mehra is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Tongue Cancer. Dr. Mehra is board certified in American Board Of Internal Medicine - Medical Oncology, 2007. Dr. Mehra is currently accepting new patients.
Frequently Asked Questions about Dr. Tanya M. Prowell
How do I make an appointment with Dr. Tanya M. Prowell?
You can book an appointment with Dr. Tanya M. Prowell by calling their office at 410-955-8964. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
What conditions does Dr. Tanya M. Prowell specialize in?
While Dr. Tanya M. Prowell is a Hematology Oncology, they have specific expertise in Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Tanya M. Prowell accept my insurance?
Dr. Tanya M. Prowell accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-8964 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers